Rassin, 2018 - Google Patents
Amino acid metabolism in total parenteral nutrition during developmentRassin, 2018
- Document ID
- 4456404681056344358
- Author
- Rassin D
- Publication year
- Publication venue
- Absorption and Utilization of Amino Acids
External Links
Snippet
The first Total parenteral nutrition (TPN) preparations used casein hydrolysates as a source of amino acids. The maturation of three pathways of amino acid metabolism appears especially relevant to total parenteral nutrition. The metabolism of phenylalanine and …
- 235000016236 parenteral nutrition 0 title abstract description 13
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Adibi | Metabolism of branched-chain amino acids in altered nutrition | |
| Lee Carter et al. | Biosynthesis and metabolism of carnitine | |
| Wu et al. | Arginine nutrition in neonatal pigs | |
| Windmueller | Glutamine utilization by the small intestine | |
| Rassin | Amino acid metabolism in total parenteral nutrition during development | |
| Te Braake et al. | Parenteral amino acid and energy administration to premature infants in early life | |
| Lund | Glutamine metabolism in the rat | |
| Tao et al. | Carnitine metabolism and its application in parenteral nutrition | |
| Seim et al. | L (-)-Carnitine and its precursor, gamma-butyrobetaine | |
| Kalhan et al. | Protein and amino acid metabolism in the human newborn | |
| Thoene et al. | Neonatal citrullinemia: Treatment with keto-analogues of essential amino acids | |
| J Ryan et al. | Interorgan metabolism of amino acids in human health and disease | |
| Nyhan et al. | Response to dietary therapy in B12 unresponsive methylmalonic acidemia | |
| Tein | Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy | |
| Melegh et al. | Effects of oral L-carnitine supplementation in low-birth-weight premature infants maintained on human milk | |
| Buist et al. | Citrullinemia: Investigation and treatment over afour-year period | |
| McReynolds et al. | Treatment of complete ornithine transcarbamylase deficiency with nitrogen-free analogues of essential amino acids | |
| Plecko et al. | Partial N-acetylglutamate synthetase deficiency in a 13-year-old girl: diagnosis and response to treatment with N-carbamylglutamate | |
| Pencharz et al. | What are the essential amino acids for the preterm and term infant? | |
| Milner | Arginine: A dietary modifier of ammonia detoxification and pyrimidine biosynthesis | |
| Tateishi et al. | The L-methionine-sparing effect of dietary glutathione in rats | |
| Boeckx et al. | Methylmalonic acidemia with the unusual complication of severe hyperglycemia. | |
| Carter | Current Concepts in Carnitine Research: A Medical College of Georgia Symposium | |
| Lal et al. | Metabolic and regulatory effects of branched chain amino acid supplementation | |
| JPH0328403B2 (en) |